August Update: Regulatory Clearance, GSBI Fellowship and SL@B

Key Milestone Achieved: Regulatory Approval in Ghana

Exactly one month after we received our regulatory approval in Kenya, we received our regulatory approval in Ghana. These regulatory approvals are a testament to Hemafuse and the hard and diligent work of our team.

With two regulatory approvals achieved, we  now have the opportunity to secure purchase orders in two key markets. Ghana is the launching point for the West African market while Kenya is the launching point for the East African market. Once we secure our next round of funding we will be well positioned to enter these two markets and then scale rapidly!

Winners of $250k Saving Lives at Birth Grant

We are proud to be the an awardee for the Saving Lives at Birth Validation Grant. This is the second stage of a grant we had been awarded 3 years ago and will fund a multi-country evaluation of Hemafuse. We will also hear in the next couple of months if we qualify for additional funds in addition to the $250k award so keep your ears tuned for even better news!

Sisu was one of just 15 submissions selected out of 550 applicants from around the globe for the prestigious grant from the U.S. Agency for International Development (USAID), the Bill & Melinda Gates Foundation, Grand Challenges Canada (funded by the Government of Canada), the Norwegian Agency for Development Cooperation (Norad), the U.K’s Department for International Development (DFID) and the Korea International Cooperation Agency (KOICA).